1. Home
  2. STZ vs UTHR Comparison

STZ vs UTHR Comparison

Compare STZ & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellation Brands Inc.

STZ

Constellation Brands Inc.

HOLD

Current Price

$140.97

Market Cap

25.5B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$549.87

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STZ
UTHR
Founded
1945
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
25.1B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
STZ
UTHR
Price
$140.97
$549.87
Analyst Decision
Buy
Buy
Analyst Count
19
14
Target Price
$175.63
$567.57
AVG Volume (30 Days)
1.8M
387.4K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
2.74%
N/A
EPS Growth
N/A
13.07
EPS
N/A
5.82
Revenue
$9,139,000,000.00
$1,483,300,000.00
Revenue This Year
$0.73
$6.39
Revenue Next Year
$1.93
$14.18
P/E Ratio
$24.93
$94.18
Revenue Growth
N/A
2.38
52 Week Low
$126.45
$272.18
52 Week High
$178.14
$609.35

Technical Indicators

Market Signals
Indicator
STZ
UTHR
Relative Strength Index (RSI) 44.08 40.52
Support Level $135.68 $464.92
Resistance Level $145.45 $608.62
Average True Range (ATR) 4.33 12.82
MACD -0.38 -2.97
Stochastic Oscillator 36.83 23.73

Price Performance

Historical Comparison
STZ
UTHR

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: